Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial
Resource Type
Article
Authors
Mosenzon, Ofri ; Wiviott, Stephen D ; Cahn, Avivit ; Rozenberg, Aliza ; Yanuv, Ilan ; Goodrich, Erica L ; Murphy, Sabina A ; Heerspink, Hiddo J L ; Zelniker, Thomas A ; Dwyer, Jamie P ; Bhatt, Deepak L ; Leiter, Lawrence A ; McGuire, Darren K ; Wilding, John P H ; Kato, Eri T ; Gause-Nilsson, Ingrid A M ; Fredriksson, Martin ; Johansson, Peter A ; Langkilde, Anna Maria ; Sabatine, Marc S ; Raz, Itamar
Source
In The Lancet Diabetes & Endocrinology August 2019 7(8):606-617
Subject
Primary Research Articles
Language
ISSN
2213-8587